PSMD10 and neoplasm: Secondly, our attempts to use CRISPR-Cas9 technology for genetic manipulation and RNA interference technology for gene knockdown of gankyrin in several TNBC cell lines were unsuccessful, thus we cannot successfully establish tumor models for further investigation of the phenomenon in vivo.